Work

Abstract 1949: ESR1 mutations in circulating tumor DNA (ctDNA) are significant predictors of chemotherapy resistance to paclitaxel and carboplatin in metastatic breast cancer (MBC)

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-1949

Authors: Qiang Zhang, Justin W. Zhang, Andrew Davis, Jianhua Jiao, Paolo D'Amico, Lorenzo Gerratana, Weijun Qin, Xinkun Wang, Akhil Chawla, Lisa Flaum, Leonidas C. Platanias, William Gradishar

Institutions: Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Washington University in St. Louis, Air Force Medical University, Merck & Co., Inc., Rahway, NJ, USA (United States), University of Udine

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409624378

Cites:

Cited by:

Related to: 10